This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Arthur J. Gallagher (AJG) Expands in UK With Lifesure Buyout
by Zacks Equity Research
Arthur J. Gallagher (AJG) strengthens its foothold in the UK with the acquisition of Lifesure Group Limited, enhancing its retail capabilities and underscoring the power of strategic acquisitions.
Factors That Make Marsh & McLennan (MMC) an Attractive Bet Now
by Zacks Equity Research
Marsh & McLennan (MMC) is well-poised for growth on its solid Risk and Insurance Services segment, as well as the prudent deployment of capital.
Brown & Brown (BRO) Rises 25% YTD: Will the Bull Run Continue?
by Zacks Equity Research
New businesses, better customer retention, premium-rate increases across the majority of business lines, strategic acquisitions and a strong financial position continue to drive Brown & Brown (BRO).
Marsh & McLennan (MMC) Unit Buys Honan to Boost Services Suite
by Zacks Equity Research
Marsh & McLennan's (MMC) unit Marsh inks an agreement to acquire Honan to boost its specialist capabilities and strengthen geographic presence.
Zacks Industry Outlook Highlights Marsh & McLennan Companies, Aon, Brown and Brown, Erie Indemnity and Ryan Specialty Holdings
by Zacks Equity Research
Marsh & McLennan Companies, Aon, Brown and Brown, Erie Indemnity and Ryan Specialty Holdings are part of the Zacks Industry Outlook article.
5 Insurance Brokerage Stocks to Benefit From Higher Demand
by Tanuka De
Increased demand for insurance products, given an aging population, baby boomers and millennials, and the adoption of technology should drive insurance brokers like MMC, AON, BRO, ERIE and RYAN.
Arthur J. Gallagher (AJG) Rises 17% YTD: More Upside Left?
by Zacks Equity Research
Solid performance of the Brokerage and Risk Management segments, strategic buyouts to capitalize on growing market opportunities and effective capital deployment continue to drive Arthur J. Gallagher's (AJG) performance.
Here is Why Growth Investors Should Buy Erie Indemnity (ERIE) Now
by Zacks Equity Research
Erie Indemnity (ERIE) possesses solid growth attributes, which could help it handily outperform the market.
Here's Why 'Trend' Investors Would Love Betting on Erie Indemnity (ERIE)
by Zacks Equity Research
Erie Indemnity (ERIE) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Add 5 Low-Beta Stocks to Your Portfolio to Counter Volatility
by Nalak Das
We have narrowed our search to five low-beta stocks. These are: DPZ, ACGL, AZPN, MLM, ERIE.
Zacks.com featured highlights PlayAGS, TETRA, Perdoceo Education, Erie Indemnity and New Oriental Education
by Zacks Equity Research
PlayAGS, TETRA, Perdoceo Education, Erie Indemnity and New Oriental Education have been highlighted in this Screen of The Week article.
5 Stocks With Recent Price Strength to Maximize Your Returns
by Nalak Das
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are AGS, TTI, PRDO, ERIE, EDU.
New Strong Buy Stocks for August 3rd
by Zacks Equity Research
ERIE, RCL, EDU, ACGL and RM have been added to the Zacks Rank #1 (Strong Buy) List on August 3, 2023.
Best Income Stocks to Buy for August 3rd
by Zacks Equity Research
ERIE, RM and HSII made it to the Zacks Rank #1 (Strong Buy) income stocks list on August 3, 2023.
Erie Indemnity (ERIE) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Erie Indemnity (ERIE) delivered earnings and revenue surprises of 17.80% and 4.49%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
eHealth (EHTH) Rallies 90% YTD: Can It Retain the Bull Run?
by Zacks Equity Research
Solid Medicare and Individual, Family and Small Business performance and financial position continue to drive eHealth (EHTH).
Arthur J. Gallagher (AJG) Shares Up 31% YTD: More Upside Left?
by Zacks Equity Research
Solid performance of the Brokerage and Risk Management segments, strategic buyouts to capitalize on growing market opportunities and effective capital deployment continue to drive Arthur J. Gallagher (AJG).
Should You Retain Willis Towers (WTW) Stock in Your Portfolio?
by Zacks Equity Research
Willis Towers (WTW) is poised to benefit from growing healthcare premiums, increased consulting work and software sales, strategic buyouts and effective capital deployment.
Best Income Stocks to Buy for June 9th
by Zacks Equity Research
CCU, AMR and ERIE made it to the Zacks Rank #1 (Strong Buy) income stocks list on June 9, 2023.
What Makes Erie Indemnity (ERIE) a New Strong Buy Stock
by Zacks Equity Research
Erie Indemnity (ERIE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Brown & Brown (BRO) Gains 10% YTD: Will the Rally Continue?
by Zacks Equity Research
New businesses, better customer retention, premium rate increases across the majority of business lines, strategic acquisitions and strong financial position continue to drive Brown & Brown (BRO)
Zacks Industry Outlook Highlights Marsh & McLennan, Aon, Brown and Brown, Erie Indemnity and Ryan Specialty
by Zacks Equity Research
Marsh & McLennan, Aon, Brown and Brown, Erie Indemnity and Ryan Specialty have been highlighted in this Industry Outlook article.
5 Stocks to Watch From the Prospering Insurance Brokerage Industry
by Tanuka De
Increased demand for insurance products, given an aging population, baby boomers and millennials, and the adoption of technology should drive insurance brokers like MMC, AON, BRO, ERIE and RYAN.
Arthur J. Gallagher (AJG) Expands Brokerage Business With Buyout
by Zacks Equity Research
Arthur J. Gallagher (AJG) boosts its brokerage and consulting business with Bernard Benefits and Bernard Healthcare Financial Planning acquisition.
Here's Why Hold is an Apt Strategy for Nasdaq (NDAQ) Stock
by Zacks Equity Research
Improving organic growth, focus on ramping up the on-trading revenue base, buyouts to capitalize on growing market opportunities, effective capital deployment poise Nasdaq (NDAQ) for growth.